SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-005412
Filing Date
2018-02-06
Accepted
2018-02-06 19:57:16
Documents
1
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 doc1.html 5  
1 FORM 5 doc1.xml 5 5444
  Complete submission text file 0001140361-18-005412.txt   6799
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Issuer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Lewicki John A. (Reporting) CIK: 0001553352 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35993 | Film No.: 18579015